Zhengyu Shi

机构：Public Health Clinical Center of Chengdu

发表论文 14 篇 · 总被引 176 次 · h-index 5

代表论文

Hyperphosphatemia and Cardiovascular Disease (2021 · Frontiers in Cell and Developmental Biology · 被引 80)
Ginsenosides Rg1 from Panax ginseng : A Potential Therapy for Acute Liver Failure Patients? (2014 · Evidence-based Complementary and Alternative Medicine · 被引 36)
Effect of a genetically engineered interferon-alpha versus traditional interferon-alpha in the treatment of moderate-to-severe COVID-19: a randomised clinical trial (2021 · Annals of Medicine · 被引 27)
Treatment Outcomes and Associated Influencing Factors Among Patients with Rifampicin-Resistant Tuberculosis: A Multicenter, Retrospective, Cohort Study in China (2024 · Infection and Drug Resistance · 被引 6)
Comparison of classical diagnostic criteria and Chinese revised diagnostic criteria for fever of unknown origin in Chinese patients (2016 · Therapeutics and Clinical Risk Management · 被引 6)
Recombinant Super-Compound Interferon (rSIFN-co) Versus Interferon Alfa in the Treatment of Moderate-to-Severe COVID-19: A Multicentre, Randomised, Phase 2 Trial (2020 · SSRN Electronic Journal · 被引 4)